Login
Contact

Explore

Explore

About
  • People and Partners
  • TRI Building
  • Reconciliation Action Plan
  • Strategic Plan
  • TRI Foundation
  • Careers
Research
  • Collaborate
  • Discovery
  • Translate
  • Engage
  • Research Areas
Clinical
  • Translational Trials
  • Clinical Research Facility
  • TRI at Children’s
Industry
  • TRI Incubator
  • The Precinct
  • Residents
Manufacture
  • New cGMP Facility
Facilities
  • Cleanroom
  • Flow Cytometry
  • Histology
  • Microscopy
  • Proteomics
  • Preclinical Imaging
  • Biological Research
  • Gnotobiotics
  • Human Immune Model
Get Involved
  • Health Consumers
  • SPARQ-ed
Resources
  • News
  • Events
  • Case Studies
  • Grants and Funding
  • Education and Training
+61 7 3443 7000info@tri.edu.au37 Kent Street, Woolloongabba QLD 4102 Australia

Acknowledgement of Country

TRI acknowledges the traditional custodians of the land we are on today, the Turrbal and Jagera people and we recognise their continuing connection to land, waters and community. We pay deep respect to them and their cultures; and to Elders past, present and emerging.

© Translational Research Institute Pty Ltd atf the Translational Research Institute Trust|ABN: 58 155 991 662
Privacy policy|Terms of Use|Contact Us
News · 29 May 2023

Seed funding for translational clinical collaborations

TRI and its hospital partners, Metro South Health (MSH), Mater Research and Children’s Health Queensland (CHQ) have jointly awarded seven new research grants to drive new clinical collaborations between early-career clinicians and scientists.

The new grants will fund innovative projects developing new treatments or diagnostics for cancers and infectious diseases, including brain, bone, pancreatic and breast cancer as well as tuberculosis and sepsis.

The grants are funded through the Leading Innovations Through New Collaborations (LINC) scheme, which provides up to $50,000 in seed funding for new research partnerships between an early or mid-career (EMC) scientist based at TRI and an EMC clinician at one of the partnering hospitals.

TRI CEO, Professor Scott Bell said the LINC grant scheme attracted good applications, with the seven successful 2022 grant applications including clinical teams from a diverse range of clinical fields such as palliative care, respiratory, intensive care, oncology and infectious diseases.

“TRI is delighted to award the LINC grants to these highly talented early and mid-career researchers and clinicians who are planning to collaborate on projects, which have promising potential for improving patient outcomes,” said Professor Bell.

 

“Through the LINC grants, TRI and our partners also hope to foster long-term, transformative research collaborations between young clinicians and academic researchers.”

Professor Scott Bell
TRI CEO

Metro South Health executive director of research Professor John Upham said the LINC grants were specifically developed to help address the significant shortage of funding available to young researchers and also to encourage junior clinicians to lead a research project.

“We strongly believe that research partnerships between clinicians and researchers are invaluable for future improvements in healthcare,” Professor Upham said.

“We were impressed by the quality and breadth of the projects awarded LINC grants this year and congratulate the five Metro South Health clinicians who received grants,” he said.

Mater Research and CHQ each awarded one LINC grant to collaborations involving their clinicians.

Mater Research executive director and director of clinical research Professor Maher Gandhi said the LINC grants played an important role in supporting new research collaborations between mater hospital clinicians and researchers at TRI.

Children’s Health Queensland director of research Associate Professor Andrew Moore said the LINC grant program provided an exciting opportunity for early-career paediatric clinicians to investigate critical areas in caring for critically unwell children.

Learn more about the LINC Grants.

Read more news

Filter by